During the past decade, Glaucoma Associates of Texas conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glaucoma Associates of Texas" #1 sponsor was "Allergan" with 2 trials, followed by "AqueSys, Inc." with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "InnFocus Inc." with 2 trials sponsored and "Santen Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glaucoma Associates of Texas" #1 collaborator was "Abbott Medical Optics" with 1 trials as a collaborator, "Alcon Research" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "DataMed Devices Inc." with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Glaucoma Associates of Texas" are "Glaucoma" (9 trials), "Ocular Hypertension" (4 trials), "Glaucoma, Open-Angle" (3 trials), "Glaucoma, Open Angle" (2 trials) and "Open Angle Glaucoma" (2 trials). Many other conditions were trialed in "Glaucoma Associates of Texas" in a lesser frequency.

Most popular intervention types in "Glaucoma Associates of Texas" are "Device" (10 trials), "Drug" (8 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trabeculectomy" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Alphagan P" (1 trials), "AqueSys Microfistula Implant" (1 trials) and "AqueSys XEN 45 Glaucoma Implant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glaucoma Associates of Texas" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Glaucoma Associates of Texas". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Glaucoma Associates of Texas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glaucoma Associates of Texas, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".